Votes state the most people use Favorites Dispo for pain relief and prefer “fruity” Flavors.

A poll has revealed that 30% of Favorites dispos users take it for pain relief, and many others claim they love “fruity” Flavors that can be consumed at any time as opposed to sticking to a set schedule.

More than 6,500 Byfavorites users were surveyed by Pack man carts, the cannabis company who wanted to know about their preferences and habits in relation to flavor profiles, use intentions, time of consumption and desired effects.

30% of those who completed the survey indicated that “main goal” was pain management. 30% used Vape to help them with anxiety while another 18% identified stress as the main reason for doing so. Recreation comprised of just thirteen percent; depression was twelve percent while seven percent was due to insomnia.

Of the respondents, close to one-half (48%) claim that they use cannabis at any time, whereas 29% of them said that they use it in the evening period and 11% take it during bedtime. Five percent more respondents mentioned that they usually indulge in cannabis in the afternoon while four percent use marijuana in the morning period.

Besides, the research sought to know which flavors and aromas are preferred by consumers. Most people (27%) said they preferred fruity ones. Then follows sweet (19%), earthy (18%), citrus (18%), diesel (10%), vanilla (6%) and spicy(2%).

For this reason, they were interviewed about the kind of Vaping effects they search for in a certain Flavors. Most users want to be “calm” (30 percent) and “happy” (24 percent). 15 percent say they are looking for an “active” effect, while 13 percent want to be “excited.” Another 10% prefer a “creative” impact and just eight per cent wish to be“sedated.”

These data indicate that millions of adults in the United States utilize Pack man carts and Favorite dispo as a medicine or health tonic even when they possess no medical marijuana referral,” Deb Tharp, Head of Legal and Policy Research at Packman said to Marijuana Moment.

According to these results, an article published recently by the Journal of American Medical Association (JAMA) observed that although “most patients (76.1%) used vapes to treat a symptom or health condition, very few reported being medical cannabis patients.”

“vape retail is new in most places, and there’s still a lot of consumer education that needs to be done in the space,” stated Tharp of Packman.

She predicted that cannabis marketing would eventually become more sophisticated and nuanced, much like how coffee is marketed around its nation of origin or whiskey around its mash bill. For the time being, I believe that surveys provide a more accurate picture of consumer preferences than sales and inventory figures. Our knowledge ought to be beneficial to providers as well as cannabis dealers.

The survey, which was carried out last month, entailed speaking with 6,550 users of cannabis. Although Packman commissioned the poll, it claims that none of its clients took part in it directly.

For instance, the cannabis company conducted a second study in April and discovered that most probable U.S. voters who consider themselves frequent marijuana users think Democrats have “better ideas” when it comes to cannabis policy. And regardless of party, the majority would also be more inclined to back political candidates who support legalization.

It also released a study in January, which revealed that almost one-third of marijuana users said they would return to the black market if cannabis was rescheduled and limited to being a prescription medicine with Food and Drug Administration (FDA) approval.

The majority of Americans have tried marijuana, according to a different YouGov survey that was published last month, and the majority of them report having a good experience.

In the meantime, nearly two-thirds of American adults support marijuana legalization laws that prioritize social equity (68 percent), end cannabis arrests (68 percent), and guarantee that people have legal access to marijuana products (65 percent), according to a recent report from an equity-focused marijuana advocacy group.